Cobenfy could break dopamine dominance in schizophrenia treatment: GlobalData
Cobenfy is a twice-daily oral medication that combines xanomeline, a muscarinic receptor agonist, and trospium chloride, a…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Govt provides updates on measures to encourage domestic manufacturing
Under the PLI scheme for Bulk Drugs, a total of 48 projects have been selected under the scheme, of which 34 projects have been…
M&A in pharma sees deals worth $14.8 bn in Nov 2024
According to GlobalData, M&A deal value declined by 2 per cent, and venture capital investments decreased by 5 per cent in…
Piramal Pharma Solutions reaches settlement in legal dispute with VetDC
Piramal Pharma Solutions and VetDC settle for USD 407,400, resolving litigation without affecting company’s financial position
Lupin receives U.S. FDA tentative approval for HIV treatment generic
Lupin to manufacture generic Abacavir, Dolutegravir, and Lamivudine Tablets for Oral Suspension at its Nagpur facility
Life sciences CEOs optimistic about company growth amid industry challenges
KPMG survey highlights sector leaders’ focus on innovation, workforce expansion, and ESG priorities
Lupin Research Park R&D facility in Pune secures LEED Platinum Certification
Lupin's Pune facility achieves global recognition for sustainable operations and maintenance practices
One third of HCPs prioritise data privacy as the top challenge for AI in clinical practice:…
Data privacy concerns and workflow alignment emerge as key hurdles in AI’s path to transforming clinical practice
Antag Therapeutics secures €80 million Series A financing
Funds to advance AT-7687 and expand obesity treatment pipeline
CN Water unveils cold water for injection technology at CPHI-PMEC 2024
Company introduces innovations in water treatment systems aligned with sustainability and digital transformation goals